Hjem › Arvelige sensoriske og autonome neuropatier › Texas
Kliniske studier for Arvelige sensoriske og autonome neuropatier i Texas
11 studier for Arvelige sensoriske og autonome neuropatier søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
Study of ACR-2316 in Specific Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06667141A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07175038A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, San Antonio
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07749586A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Texas Oncology - Central/South Texas, Austin
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- og 2 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- og 1 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
- Texas Oncology - Central/South, Austin
- START San Antonio, San Antonio
- Texas Oncology - San Aantonio, San Antonio
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT06993844A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Texas Oncology - Flower Mound, Flower Mound
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 22. apr. 2026 · NCT05683418Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- El Paso Texas Oncology, El Paso
- Texas Oncology San Antonio, San Antonio
RekruttererObservasjonsstudie
Alder 1 til 100 · Alle kjønn · Oppdatert 1. apr. 2026 · NCT05868629A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
- Research Site, Houston
RekruttererFase 1
Alder 18 til 110 · Alle kjønn · Oppdatert 2. mar. 2026 · NCT07064122Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Texas Oncology - West Texas, El Paso
- Texas Oncology - Gulf Coast, The Woodlands
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 24. des. 2025 · NCT06463028Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.